Clinical Trial Update: Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This document reports results from a Phase 3 trial evaluating Biphasic Insulin Aspart 50 for blood glucose control in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-03-31